Headache

Article	Citations
Identifying cognitive‐affective mechanisms underlying disability in episodic migraine: Using the fear avoidance model to examine interactions	124
Evidence for increased background neural noise in migraine with aura: Hyperactive but not hyperresponsive	96
Persistence, effectiveness, and tolerability of anti‐calcitonin gene–related peptide monoclonal antibodies in patients with chronic migraine	80
Virtual issue: Education in headache medicine: Insights and advancements from 2023 to 2024	57
Effect of caffeine and caffeine cessation on cerebrovascular reactivity in patients with migraine	56
A 52‐week open‐label extension study to evaluate the safety and efficacy of oral rimegepant for the preventive treatment of migraine	43
Drug‐resistant epicrania fugax: Responding to onabotulinumtoxinA	41
Anxiety, depression, and headache‐related disability in a large pediatric clinic–based sample	39
Erratum	38
Migraine screening in English and Spanish	38
Pilot study evaluating treatment with sumatriptan for moderate to severe post‐traumatic headache: A phase 2 open‐label study	32
A retrospective analysis of the use of candesartan for migraine prevention in adolescents	32
Assessing the influence of migraine on ischemic penumbra and on the prognosis of ischemic stroke: A prospective cohort study	30
Popping the balloon: Abrupt onset of a spinal CSF leak and spontaneous intracranial hypotension in idiopathic intracranial hypertension, a case report	30
Migraine and peripheral pain models show differential alterations in neuronal complexity	29
Normal glymphatic system function in patients with new daily persistent headache using diffusion tensor image analysis along the perivascular space	29
Facial variant of epicrania fugax secondary to a cerebellopontine angle meningioma	29
Genetic migraine disorders and the response to calcitonin gene‐related peptide antagonist treatment	29
The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine	28
Migraine treatment in pregnancy: A survey of comfort and treatment practices of women's healthcare providers	28
Characteristics associated with response to subcutaneously administered anti‐CGRP monoclonal antibody medications in a real‐world community cohort of persons living with migraine: A retrospective clin	28
Developing and delivering a migraine disparities and diagnosis undergraduate medical educational program to underrepresented in medicine medical student members of the Student National Medical Associa	27
Neuromodulation for primary headache disorders: Advantages and challenges	27
Index	26
Sequential administration of peripheral nerve blocks and  onabotulinumtoxinA for the treatment of chronic migraine and other headache disorders—A ret	26

Sex and gender: Opportunities to expand research and understanding within headache medicine	25
A retrospective review of sex differences of white matter hyperintensities in brain MRI of patients with migraine	25
Skin wetness sensitivity across body sites commonly affected by pain in people with migraine	25
Effects of fremanezumab on migraine‐associated symptoms and medication use in Japanese and Korean patients with episodic migraine: Exploratory endpoint analysis of a multicenter, randomized, double‐bl	25
Effect of erenumab versus other migraine preventive medications on cardiovascular and cerebrovascular outcomes: A United States claims database‐based observational cohort study	24
Patient preference for early onset of efficacy of preventive migraine treatments	24
Patients with chronic post‐dural puncture headache do not have typical imaging features of intracranial hypotension: An MRI study using the Bern scor	23
TRPM3 activation causes CGRP release in trigeminal neurons: Implications for migraine mechanisms	23
Patient headache questionnaires can improve headache diagnosis and treatment in children	23
Headache and psychological variables as predictors of disability in individuals with primary headache disorders	23
Dietary sodium and headache are linked by cerebrospinal fluid sodium concentration to sodium‐specific appetite, tolerance, and perceptive reward	23
CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivity	22
Prevalence of primary stabbing headache: A meta‐analysis	22
Crystal‐clear days and unclear days in migraine: A population‐based study	22
The teaching of headache medicine in France: A questionnaire‐based study	22
Long‐term efficacy and safety of erenumab in patients with chronic migraine and acute medication overuse: A subgroup analysis	22
Patient‐reported experiences with migraine‐related cognitive symptoms: Results of the MiCOAS qualitative study	22
Challenges and opportunities for estimating and assessing migraine prevalence, incidence and impact across study populations and methodologies: Bridging global and United Stat	21
Intravenous magnesium and methocarbamol for acute pain crises in refractory trigeminal neuralgia: A retrospective analysis	21
OnabotulinumtoxinA as a promising treatment for primary trochlear headache: A retrospective case series	21
Treatment effectiveness of galcanezumab versus traditional oral migraine preventive medications at 3 months: Results from the TRIUMPH study	21
	21
Assessing blood pressure changes and hypertension‐related outcomes in patients with migraine treated with erenumab: A systematic review and meta‐analysis	20
The 2024 Headache editorial board Conflict of Interest Declarations	19
Issue Information	19
Validation of a Portuguese version of the four‐item Migraine Interictal Burden Scale	18
Headache and acute cerebrovascular disease: How do we differentiate primary and secondary headache disorders in the emergency setting?	18
Recurrent painful ophthalmoplegic neuropathy with headache and oculomotor palsy 18 years apart	18
The elephant in the room: How the underfunding of headache research stunts the field	17
Sustained benefits of onabotulinumtoxinA treatment in chronic migraine: An analysis of the pooled Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) randomized controlled trials	17
Protracted headache after COVID‐19: A case series of 31 patients from a tertiary headache center	17
Remote electrical neuromodulation to treat children and adolescents with migraine in the emergency department: A randomized double‐dummy pilot trial	17
Evaluation of vascular risk in patients with migraine with and without aura treated with erenumab: Post hoc analysis of pooled long‐term clinical trial data	17
Changes in cognitive appraisal in a randomized controlled trial of mindfulness‐based cognitive therapy for patients with migraine	17
Alcohol as a trigger of migraine attacks in people with migraine. Results from a large prospective cohort study in English‐speaking countries	16
A large language model–based generative natural language processing framework fine‐tuned on clinical notes accurately extracts headache frequency from electronic health records	16
Prevalence, characteristics, and factors associated with caffeine‐withdrawal headache during the first day of Ramadan	16
Dystonia phenomenology and treatment response in migraine	16
Post‐vaccination headache reporting: Trends according to the Vaccine Adverse Events Reporting System	16
Socioeconomic and geographic inequalities in headache disability in Brazil: The 2019 National Health Survey	16
Engagement and predictors of use of a smartphone app for migraine self‐management: A secondary analysis of the EMMA trial	16
Plain Language Summary Publication: Investigating the causal and genetic relationship between migraine and Parkinson’s disease	15
Different dosage regimens of erenumab for the treatment of migraine: A systematic review and meta‐analysis of the efficacy and safety of randomized controlled trials	15
Development and pharmacological characterization of novel multi‐ calcitonin gene‐related peptide and pituitary adenylate cyclase‐activating peptide receptor antagonists	15
Clinical factors associated with day‐to‐day peak pain severity in individuals with chronic migraine: A cohort study using daily prospective diary data	15
Challenges in the management of new daily persistent headache at a tertiary headache center—A retrospective real‐world evidence study	15
The cortical spreading depression/migraine aura hypothesis – Finally some definitive evidence	15
Effect of galcanezumab in women with episodic migraine meeting criteria for menstrually related migraine: A post hoc analysis of EVOLVE ‐1 and	15
Afterimage duration differs for migraine with or without aura	15
Essential components of care in a multidisciplinary headache center: Perspectives from headache neurology specialists	15

Red flags in headache care	15
Melatonin for migraine prevention in children and adolescents: A randomized, double‐blind, placebo‐controlled trial after single‐blind placebo lead‐in	15
Issue Information	15
Burden of migraine in Brazil: A cross‐sectional real‐world study	15
	14
Basic Science Prize Award 2024	14
The 2025 Headache Editorial Board conflict of interest declarations	14
Eicosapentaenoic acid versus placebo as adjunctive therapy in chronic migraine: A randomized controlled trial	14
Decision‐making impairment under ambiguity but not under risk may underlie medication overuse in patients with chronic migraine	14
Headache in individuals undergoing hormone therapy for gender transition: A cross‐sectional, observational study	14
Emergency department utilization among patients who receive outpatient specialty care for headache: A retrospective cohort study analysis	14
Plain Language Summary Publication: The 2023 protocol for update to acute treatment of adults with migraine in the emergency department: The American headache society evidence assessment of parenteral	14
Issue Information	14
Prediction of individual trigeminal pain sensitivity from gray matter structure within the sensorimotor network	14
Beyond aura: Understanding migraine as a cycling pan‐sensory threshold disease	13
Effect of wildfire smoke on primary headache disorders remains unclear	13
Essential but often overlooked reporting elements for Headache manuscripts	13
Reducing the physical, social, and emotional impact of episodic migraine: Results from erenumab STRIVE and ARISE phase III randomized trials	13
Plasma calcitonin gene–related peptide and nerve growth factor as headache and pain biomarkers in recently deployed soldiers with and without a recent concussion	13
Characterization of trigeminal C‐fiber reactivity through capsaicin‐induced release of calcitonin gene‐related peptide	13
Clinical characteristics and patient‐reported outcomes of chronic and episodic migraine patients at a US tertiary headache center: A retrospective observational study	13
Secondary nummular headache: Are they more common than we thought?	13
American Headache Society 64th Annual Scientific Meeting June 9–12, 2022 Denver, Colorado	13
Letters from nobody: The problem of AI ‐written Letters to the Editor	12
Headache in transgender men using gender‐affirming hormone therapy: A case–control study	12
Intracranial hypotension as a contributor to isolated cortical vein thrombosis	12
Factors associated with efficacy of occipital nerve stimulation in medically intractable chronic cluster headache	12
Efficacy and safety of rimegepant for the acute treatment of migraine in Japan: A dose‐ranging, double‐blind, randomized controlled trial	12
Arachnoid granulations in idiopathic intracranial hypertension: Do they have an influence?	12
Issue Information	12
The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice	12
Digital headache self‐management interventions for patients with a primary headache disorder: A systematic review of randomized controlled trials	11
Response to: Disagreement with Categorization of Clinical Trials included in Treadwell et al. Systematic Review and Meta‐Analysis	11
Correction to “Smartphone‐delivered progressive muscle relaxation for the treatment of migraine in primary care: A randomized controlled trial”	11
Improving distress perception and mutuality in migraine caregivers after 6 months of galcanezumab treatment	11
Comparison and predictors of chronic migraine vs. new daily persistent headache presenting with a chronic migraine phenotype	11
Causal associations between genetically predicted placental weight and migraine	11
Insomnia severity in migraine: The role of headache frequency, aura status, and comorbidities—A cross‐sectional study	11
Cluster Analysis of Migraine‐associated Symptoms (CAMS) in youth: A retrospective cross‐sectional multicenter study	11
Are psychological interventions efficacious for adults with migraine? A systematic review and meta‐analysis	11
Zavegepant nasal spray for the acute treatment of migraine: A Phase 2/3 double‐blind, randomized, placebo‐controlled, dose‐ranging trial	11
Long‐term effectiveness of eptinezumab in the treatment of patients with chronic migraine and medication‐overuse headache	11
Beyond movement: Headache in patients with functional movement disorders	11
	10
Visual hypersensitivity in patients treated with anti‐calcitonin gene–related peptide (receptor) monoclonal antibodies	10
Exploring the impact of acute SARS‐CoV‐2 infection on headache pattern in patients with migraine: A novel Bayesian analysis	10
Glial activation in pain and emotional processing regions in the nitroglycerin mouse model of chronic migraine	10
The impact of updates in headache quality measures on adherence to best practices in a neurology resident clinic: A quality improvement study	10
Plain Language Summary Publication: Evaluating the use of paracetamol to prevent fasting headache during the first week of Ramadan: A randomized, open‐label, clinical trial	10
The link between reversible cerebral vasoconstriction syndrome and transient global amnesia	10
Post hoc analysis of clinical trial data and pharmacokinetic data to assess wearing‐off of erenumab within monthly treatment cycle	10
Issue Information	10
Issue Information	9
The importance of patient and family perspectives of clinical decisions in pediatric headache	9
Migraine, idiopathic intracranial hypertension, and calcitonin gene‐related peptide antibodies	9
Issue Information	9
Mechanisms of change in posttraumatic headache–related disability: A mediation model	9
Migraine and infertility, merging concepts in women's reproductive health: A narrative review	9
	9
Celebrating Headache 's 2023 graduating class of Assistant Editors	9
Symptomatic visual snow in acute ischemic stroke: A case series	9
2025 guideline update to acute treatment of migraine for adults in the emergency department: The American Headache Society evidence assessment of parenteral pharmacotherapies	9
Development and validation of a novel patient‐reported outcome measure in people with episodic migraine and chronic migraine: The Activity Impairment in Migraine Diary	9
Validity of self‐reported migraine in adolescents and children	9
Time to reconsider the association between migraine and white matter hyperintensities?	9
The pathogenic role of calcitonin gene‐related peptide and predictors of new‐onset migraine and long‐term outcomes after transcatheter atrial septal defect closure	9
Migraine in the context of chronic primary pain, chronic overlapping pain disorders, and functional somatic disorders: A narrative review	9
Headache diagnosis and treatment: A pilot knowledge and needs assessment among physical therapists	9
A post hoc analysis of migraine‐associated symptoms from the phase 3 randomized, double‐blind, sham‐controlled Trial of External trigeminal nerve stimulation for the Acute treatment of Migraine (	9
Migraine epidemiology in collegiate student‐athletes: Findings from the Concussion Assessment, Research, and Education (CARE) Consortium	9
A randomized trial of ketorolac and metoclopramide for migraine in the emergency department	9
Blink reflex: A practical test to evaluate the trigeminal nerve injury following percutaneous balloon compression for the treatment of trigeminal neuralgia	9
Magnetoencephalography studies in migraine and headache disorders: A systematic review	9
Heavy metal and trace element alterations in patients during a migraine attack	8
Identifying and predicting headache trajectories among those with acute post‐traumatic headache	8
Exploratory investigation of a patient‐informed low‐dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double‐blind, placebo‐controlled trial	8
	8
Machine learning models and classification algorithms in the diagnosis of vestibular migraine: A systematic review and meta‐analysis	8
Virtual issue: Recent advances in pediatric headache: Bridging the data gap	8
Healthcare costs and resource utilization in patients with migraine treated with erenumab: A retrospective, non‐interventional study using claims data from the United States	8

Issue Information	8
The effectiveness of parenteral agents for pain reduction in patients with migraine presenting to emergency settings: A systematic review and network analysis	8
Circadian functional changes of pain‐processing brainstem nuclei and implications for cluster headache: A 7 Tesla imaging study	8
Effectiveness and tolerability of galcanezumab for migraine prevention in patients ≥65 years: A real‐life multicenter study	8
Real‐world barriers to health care utilization among people living with migraine: Insights from the All of Us Research Program	8
Long‐term evolution of white and gray matter structural properties in migraine	8
Trainee highlights	8
Different characteristics of cortical spreading depression in the sleep and wake states	8
American Headache Society 67th Annual Scientific Meeting June 19–22, 2025 Minneapolis, Minnesota	8
Letter to the Editor regarding “Impact of perilesional edema on severity of migraine in patients with calcified neurocysticercosis: A prospective evaluation”	8
Patient headache questionnaires can improve headache diagnosis and treatment in children	8
The Chronic Headache Self‐Efficacy Scale: Development and assessment of measurement properties	8
Cerebrovascular reactivity to hypercapnia in patients with migraine: A dual‐echo arterial spin labeling MRI study	8
	8
Indomethacin‐responsive idiopathic red ear syndrome: A pediatric case	8
Efficacy of an educational website on headaches in schoolchildren: A cluster‐randomized controlled trial	8
Neuropathic changes in corneal nerve endings—A potential objective biomarker for migraine frequency and response to treatment	8
	8
A critical appraisal of the International Classification of Headache Disorders migraine diagnostic criteria based on a retrospective multicenter cross‐sectional headache registry study in youth	8
Counting the cost: How migraine shapes lives and economies	8
	7
Comparative prevalence and characteristics of fabricated citations in large language models in headache medicine	7
Evaluating associations of migraine‐related vertigo	7
The impact of fear of attacks on pain‐related disability in cluster headache: Insights from the fear avoidance model	7
A placebo controlled, randomized clinical trial of galcanezumab for vestibular migraine: The INVESTMENT study	7
Multi‐region local field potential signatures and brain coherence alternations in response to nitroglycerin‐induced migraine attacks	7
Habitual caffeinated beverage consumption and headaches among adults with episodic migraine: A prospective cohort study	7
Preliminary exploration of a multidimensional sleep health composite in adolescent females with frequent migraine	7
Headache basic science prize	7
The 15‐day threshold in the definition of chronic migraine is reasonable and sufficient—Five reasons for not changing the ICHD‐3 definition	7
Insight of a headache medicine provider in Indian Health Service: A personal and professional observation	7
Baseline factors associated with post‐stenting intracranial pressure in patients with idiopathic intracranial hypertension with venous sinus stenosis	7
Diagnostic accuracy of an artificial intelligence online engine in migraine: A multi‐center study	7
Sustained response of galcanezumab in migraine prevention: Patient‐level data from a post hoc analysis in patients with episodic or chronic migraine	7
Welcoming Headache 's 2024 incoming class of Assistant Editors	7
Intranasal treatment of cluster headache: A response	7
Correction to “A causative role for remote dural puncture and resultant arachnoid bleb in new daily persistent headache: A case report”	7
Heightened migraine risk in patients with rheumatoid arthritis: A national retrospective cohort study	7
Investigating the effects of weather on headache occurrence using a smartphone application and artificial intelligence: A retrospective observational cross‐sectional study	7
Asking the right questions: The value of headache specialty care	7
Headache launches the publication of plain language summaries	7
Cost per treatment responder analysis of atogepant compared to rimegepant for the preventive treatment of episodic migraine	7
Trainee highlights	6
Potential drug interaction between calcitonin gene‐related peptide antagonists and neonatal Fc receptor inhibitors	6
Phenotype of midfacial pain in 12 new cases—A multidisciplinary idiopathic facial pain syndrome	6
A multicenter, prospective, single‐arm study of 60‐day peripheral nerve stimulation of the occipital nerves for the treatment of headache	6
Efficacy of galcanezumab in proline‐rich transmembrane protein 2 ( PRRT2 )	6
Spontaneous involution of a large pineal cyst: Case report and narrative review	6
Patient preferences for preventive migraine treatments among Canadian adults: A discrete choice experiment	6
Are there differences between patients with unifocal nummular headache and those who progress to bifocal nummular headache? A retrospective observational study	6
	6
New insight into the neural mechanisms of migraine in adolescents: Relationships with sleep	6
Study participant impression of use and satisfaction with STS101 (dihydroergotamine nasal powder): Results from the open‐label ASCEND acute migraine study	6
Sex‐specific differences in the relationship between AHA Life's Essential 8 factors and migraine disorders: A cross‐sectional evaluation in	6
Plain Language Summary Publication: Regulation of headache response and transcriptomic network by the trigeminal ganglion clock	6
Twenty twenty … two: Headache and COVID‐19	6
Sex influences the progression of cephalic mechanical and light hypersensitivities in a mouse model of chronic migraine	6
A multicenter, randomized, double‐blind, placebo‐controlled, crossover trial to evaluate the efficacy and safety of zolmitriptan nasal spray for the acute treatment of migraine in patients aged 6 to 1	6
A qualitative evidence synthesis of patient perspectives on migraine treatment features and outcomes	6
Issue Information	6
Challenges and complexities in designing cluster headache prevention clinical trials: A narrative review	6
Effects of multiple‐dose administration of zavegepant nasal spray on the single‐dose pharmacokinetics of ethinyl estradiol‐levonorgestrel	6
Challenges and complexities in designing cluster headache prevention clinical trials: A narrative review	6
Headache neuroimaging: A survey of current practice, barriers, and facilitators to optimal use	6
Altered brain functional connectivity in patients with tension‐type headache	6
Good News? Bad News? Idiopathic intracranial hypertension and migraine	6
Issue Information	6
Lacosamide for refractory trigeminal neuralgia and other facial pain—Case report	6
Ramadan fasting in smokers with primary headache disorders: Impact of nicotine dependence on headache frequency and severity	6
Alterations in the structure and function of the brain in adolescents with new daily persistent headache: A pilot MRI study	6
Trainee highlights	6
Blood serum levels of PACAP and migraine onset: A systematic review and meta‐analysis of observational studies	6
Patterns of clinical and imaging presentations in patients with spontaneous intracranial hypotension due to spinal cerebrospinal fluid venous fistula: A single‐center retrospective cross‐sectional stu	6
	6
The complex relationship between alcohol and migraine	6
Pain medication beliefs in individuals with headache	6
Learning headache triggers through experience: A laboratory study	6
	6
Issue Information	5
The effect of different exercise types on migraine frequency in individuals with migraine: A pilot study	5
Comprehensive assessment of erenumab efficacy in participants with high‐frequency episodic migraine with at least one previously failed preventive treatment: The EMBRACE	5
Impact of the 2018 Japan Floods on prescriptions for migraine: A longitudinal analysis using the National Database of Health Insurance Claims	5
Cardiovascular risk and triptan usage among patients with migraine	5
Safety of remote electrical neuromodulation for acute migraine treatment in pregnant women: A retrospective controlled survey‐study	5
Headache associated with COVID‐19: Epidemiology, characteristics, pathophysiology, and management	5
Epidemiology of new daily persistent headache: A systematic review and meta‐analysis with comparison in regard to different age groups, sex, and patient sample settings	5
A phase 1, multicenter, open‐label study to evaluate the pharmacokinetics, safety, and tolerability of a single dose of rimegepant in children (aged ≥6 to <12 years) with a history of migraine	5
Cerebrospinal fluid and serum biomarkers in idiopathic intracranial hypertension: A systematic review	5
Adverse childhood experiences and onset of migraine in Canadian adolescents: A cohort study	5
Exploring the relationship between pain catastrophizing and migraine in youth: A longitudinal clinical cohort study	5
Safety, tolerability, and pharmacokinetics of single and multiple ascending doses of zavegepant nasal spray in healthy adults from two phase 1 randomized, placebo‐controlled trials	5
Occipital condyle syndrome due to small‐cell lung carcinoma: A case report	5
Building a national headache medicine research network: The BE WELL with Migraine Champion Providers Network™	5
Bridging the gap between preclinical scientists, clinical researchers, and clinicians: From animal research to clinical practice	5
Diagnosis, consultation, treatment, and impact of migraine in the US: Results of the OVERCOME (US) study	5